Myocardial perfusion MRI shows impaired perfusion of the mouse hypertrophic left ventricle

International Journal of Cardiovascular Imaging

Volumn 30, Issue 3, 2014, Pages 619-628

  Van Nierop, Bastiaan J ^a   Coolen, Bram F ^b   Bax, Noortje A ^a   Dijk, Wouter J R ^a   Van Deel, Elza D ^c   Duncker, Dirk J ^c   Nicolay, Klaas ^a   Strijkers, Gustav J ^a  

^a EINDHOVEN UNIVERSITY OF TECHNOLOGY   (Netherlands)

^b ACADEMIC MEDICAL CENTER   (Netherlands)

^c ERASMUS MEDICAL CENTER   (Netherlands)

Author keywords

First pass perfusion; Heart failure; Hypertrophy; Mouse; MRI; Transverse aortic constriction

Indexed keywords

GADOLINIUM PENTETATE; CONTRAST MEDIUM;

ANIMAL EXPERIMENT; ANIMAL MODEL; AORTA CONSTRICTION; ARTICLE; BODY WEIGHT; CARDIOVASCULAR MAGNETIC RESONANCE; CONTRAST ENHANCEMENT; CONTROLLED STUDY; HEART FAILURE; HEART LEFT VENTRICLE EJECTION FRACTION; HEART LEFT VENTRICLE FUNCTION; HEART LEFT VENTRICLE HYPERTROPHY; HEART LEFT VENTRICLE OVERLOAD; HEART LEFT VENTRICLE SIZE; HEART MUSCLE PERFUSION; MOUSE; MYOCARDIAL PERFUSION IMAGING; NONHUMAN; NUCLEAR MAGNETIC RESONANCE SCANNER; TRANSVERSE AORTIC CONSTRICTION; ANALYSIS OF VARIANCE; ANIMAL; C57BL MOUSE; COMPLICATION; CORONARY ARTERY BLOOD FLOW; DIAGNOSTIC USE; DISEASE MODEL; FOLLOW UP; HEART VENTRICLE; IMAGE ENHANCEMENT; NUCLEAR MAGNETIC RESONANCE IMAGING; PATHOPHYSIOLOGY; PROCEDURES; REPRODUCIBILITY; STENOSIS, OCCLUSION AND OBSTRUCTION;

ANALYSIS OF VARIANCE; ANIMALS; CONSTRICTION, PATHOLOGIC; CONTRAST MEDIA; CORONARY CIRCULATION; DISEASE MODELS, ANIMAL; FOLLOW-UP STUDIES; GADOLINIUM DTPA; HEART FAILURE; HEART VENTRICLES; HYPERTROPHY, LEFT VENTRICULAR; IMAGE ENHANCEMENT; MAGNETIC RESONANCE IMAGING; MICE; MICE, INBRED C57BL; REPRODUCIBILITY OF RESULTS;

EID: 84899048684     PISSN: 15695794     EISSN: 15730743     Source Type: Journal    
DOI: 10.1007/s10554-014-0369-0     Document Type: Article

References (42)

1. Denolin H, Kuhn H, Krayenbuehl HP et al (1983) The definition of heart failure. Eur Heart J 4(7):445-448 (Pubitemid 13031774)
2. Juenger J, Schellberg D, Kraemer S et al (2002) Health related quality of life in patients with congestive heart failure: comparison with other chronic diseases and relation to functional variables. Heart 87(3):235-241 (Pubitemid 34177677)
3. de Couto G, Ouzounian M, Liu PP (2010) Early detection of myocardial dysfunction and heart failure. Nat Rev Cardiol 7(6):334-344
4. Lloyd-Jones D, Adams RJ, Brown TM et al (2010) Heart disease and stroke statistics - 2010 update: a report from the American Heart Association. Circulation 121(7):e46-e215
5. McMurray JJ, Stewart S (2000) Epidemiology, aetiology, and prognosis of heart failure. Heart 83(5):596-602 (Pubitemid 30316742)
6. Cokkinos DV, Pantos C (2011) Myocardial remodeling, an overview. Heart Fail Rev 16:1-4
7. Frey N, Olson EN (2003) Cardiac hypertrophy: the good, the bad, and the ugly. Annu Rev Physiol 65:45-79 (Pubitemid 38249147)
8. Neubauer S (2007) The failing heart - an engine out of fuel. N Engl J Med 356(11):1140-1151
9. Shiojima I, Sato K, Izumiya Y et al (2005) Disruption of coordinated cardiac hypertrophy and angiogenesis contributes to the transition to heart failure. J Clin Invest 115(8):2108-2118 (Pubitemid 41134152)
10. Vatner SF, Hittinger L (1993) Coronary vascular mechanisms involved in decompensation from hypertrophy to heart failure. J Am Coll Cardiol 22(4 Suppl A):34A-40A (Pubitemid 23285794)
11. Mathiassen ON, Buus NH, Sihm I et al (2007) Small artery structure is an independent predictor of cardiovascular events in essential hypertension. J Hypertens 25(5):1021-1026 (Pubitemid 46573121)
12. Levy BI, Schiffrin EL, Mourad JJ et al (2008) Impaired tissue perfusion: a pathology common to hypertension, obesity, and diabetes mellitus. Circulation 118(9):968-976
13. Dai Z, Aoki T, Fukumoto Y et al (2012) Coronary perivascular fibrosis is associated with impairment of coronary blood flow in patients with non-ischemic heart failure. J Cardiol 60(5):416-421
14. Hoenig MR, Bianchi C, Rosenzweig A et al (2008) The cardiac microvasculature in hypertension, cardiac hypertrophy and diastolic heart failure. Curr Vasc Pharmacol 6(4):292-300
15. Cecchi F, Olivotto I, Gistri R et al (2003) Coronary microvascular dysfunction and prognosis in hypertrophic cardiomyopathy. N Engl J Med 349(11):1027-1035 (Pubitemid 37087617)
16. Nakajima H, Onishi K, Kurita T et al (2010) Hypertension impairs myocardial blood perfusion reserve in subjects without regional myocardial ischemia. Hypertens Res 33(11):1144-1149
17. Hartley CJ, Reddy AK, Madala S et al (2008) Doppler estimation of reduced coronary flow reserve in mice with pressure overload cardiac hypertrophy. Ultrasound Med Biol 34(6):892-901 (Pubitemid 351697604)
18. Givvimani S, Munjal C, Gargoum R et al (2011) Hydrogen sulfide mitigates transition from compensatory hypertrophy to heart failure. J Appl Physiol 110(4):1093-1100
19. Oudit GY, Kassiri Z, Zhou J et al (2008) Loss of PTEN attenuates the development of pathological hypertrophy and heart failure in response to biomechanical stress. Cardiovasc Res 78(3):505-514 (Pubitemid 351769769)
20. van Deel ED, de Boer M, Kuster DW et al (2011) Exercise training does not improve cardiac function in compensated or decompensated left ventricular hypertrophy induced by aortic stenosis. J Mol Cell Cardiol 50(6):1017-1025
21. Streif JUG, Nahrendorf M, Hiller K-H et al (2005) In vivo assessment of absolute perfusion and intracapillary blood volume in the murine myocardium by spin labeling magnetic resonance imaging. Magn Reson Med 53(3):584-592 (Pubitemid 40332278)
22. Jacquier A, Kober F, Bun S et al (2011) Quantification of myocardial blood flow and flow reserve in rats using arterial spin labeling MRI: comparison with a fluorescent microsphere technique. NMR Biomed 24(9):1047-1053
23. Decking UKM, Pai VM, Bennett E et al (2004) High-resolution imaging reveals a limit in spatial resolution of blood flow measurements by microspheres. Am J Physiol Heart Circ Physiol 287(3):H1132-H1140 (Pubitemid 39096658)
24. Coolen BF, Moonen RPM, Paulis LEM et al (2010) Mouse myocardial first-pass perfusion MR imaging. Magn Reson Med 64(6):1658-1663
25. Makowski M, Jansen C, Webb I et al (2010) First-pass contrast-enhanced myocardial perfusion MRI in mice on a 3-T clinical MR scanner. Magn Reson Med 64(6):1592-1598
26. van Nierop BJ, Coolen BF, Dijk WJR et al (2012) Quantitative first-pass perfusion MRI of the mouse myocardium. Magn Reson Med 69(6):1735-1744
27. Rockman HA, Ross RS, Harris AN et al (1991) Segregation of atrial-specific and inducible expression of an atrial natriuretic factor transgene in an in vivo murine model of cardiac hypertrophy. Proc Natl Acad Sci USA 88(18):8277-8281 (Pubitemid 21915339)
28. van Nierop BJ, van Assen H, van Deel ED et al (2013) Phenotyping of left and right ventricular function in mouse models of compensated hypertrophy and heart failure with cardiac MRI. PLoS One 8(2):e55424
29. Köstler H, Ritter C, Lipp M et al (2004) Prebolus quantitative MR heart perfusion imaging. Magn Reson Med 52(2):296-299 (Pubitemid 39025273)
30. Jerosch-Herold M, Wilke N, Stillman AE (1998) Magnetic resonance quantification of the myocardial perfusion reserve with a Fermi function model for constrained deconvolution. Med Phys 25(1):73-84 (Pubitemid 28063691)
31. Valentinuzzi ME, Geddes LA, Baker LE (1969) A simple mathematical derivation of the Stewart-Hamilton formula for the determination of cardiac output. Med Biol Eng 7(3):277-282
32. Kawecka-Jaszcz K, Czarnecka D, Olszanecka A et al (2008) Myocardial perfusion in hypertensive patients with normal coronary angiograms. J Hypertens 26(8):1686-1694
33. Izumiya Y, Shiojima I, Sato K et al (2006) Vascular endothelial growth factor blockade promotes the transition from compensatory cardiac hypertrophy to failure in response to pressure overload. Hypertension 47(5):887-893 (Pubitemid 44297560)
34. Duncker DJ, de Beer VJ, Merkus D (2008) Alterations in vasomotor control of coronary resistance vessels in remodelled myocardium of swine with a recent myocardial infarction. Med Biol Eng Comput 46(5):485-497
35. Bache RJ (1988) Effects of hypertrophy on the coronary circulation. Prog Cardiovasc Dis 30(6):403-440
36. Kober F, Iltis I, Cozzone PJ et al (2004) Cine-MRI assessment of cardiac function in mice anesthetized with ketamine/xylazine and isoflurane. Magn Reson Mater Phys Biol Med 17(3-6):157-161 (Pubitemid 40362298)
37. You J, Wu J, Ge J et al (2012) Comparison between adenosine and isoflurane for assessing the coronary flow reserve in mouse models of left ventricular pressure and volume overload. Am J Physiol Heart Circ Physiol 303(10):H1199-H1207
38. Braunwald E (1971) Control of myocardial oxygen consumption: physiologic and clinical considerations. Am J Cardiol 27(4):416-432
39. Soler R, Rodríguez E, Monserrat L et al (2006) Magnetic resonance imaging of delayed enhancement in hypertrophic cardiomyopathy: relationship with left ventricular perfusion and contractile function. J Comput Assist Tomogr 30(3):412-420 (Pubitemid 43922258)
40. Gould KL, Carabello BA (2003) Why angina in aortic stenosis with normal coronary arteriograms? Circulation 107(25):3121-3123 (Pubitemid 36793078)
41. Gao X-M, Kiriazis H, Moore X-L et al (2005) Regression of pressure overload-induced left ventricular hypertrophy in mice. Am J Physiol Heart Circ Physiol 288(6):H2702-H2707 (Pubitemid 40720648)
42. Kober F, Iltis I, Cozzone PJ et al (2005) Myocardial blood flow mapping in mice using high-resolution spin labeling magnetic resonance imaging: influence of ketamine/xylazine and isoflurane anesthesia. Magn Reson Med 53(3):601-606 (Pubitemid 40332280)